Anti-Mullerian Hormone as Predictor of Future and Ongoing Bone Loss During the Menopause Transition.
Saved in:
| Title: | Anti-Mullerian Hormone as Predictor of Future and Ongoing Bone Loss During the Menopause Transition. |
|---|---|
| Authors: | Karlamangla AS; David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Shieh A; David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Greendale GA; David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Yu EW; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Burnett-Bowie SM; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Sluss PM; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Martin D; University of Pittsburgh, Pittsburgh, PA, USA., Morrison A; Motive Biosciences Inc, Webster, TX, USA., Finkelstein JS; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. |
| Source: | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2022 Jul; Vol. 37 (7), pp. 1224-1232. Date of Electronic Publication: 2022 Apr 04. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 8610640 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-4681 (Electronic) Linking ISSN: 08840431 NLM ISO Abbreviation: J Bone Miner Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1523-4681 |
|---|---|
| DOI: | 10.1002/jbmr.4525 |
